Circulating TGF-β levels were higher in severe post-COVID-19 patients with lung fibrosis events. (A) Plasma levels of TGF-β were measured in healthy, vaccinated (VAX) subjects (black and green dots, respectively), and post-COVID-19 (PC) patients (red dots), according to the grade of the pathology (moderate vs. severe, pink and blue dots, respectively). (B) TGF-β levels were evaluated according to the establishment of lung fibrosis symptoms (moderate or severe PC patients with or without fibrosis, pink or blue dots and purple and bright blue dots, respectively). Data are expressed as median. Statistical analysis was performed according to the Mann–Whitney U test.